AAV9-CRiSPR/Cas9 preclinical trial on patient-derived FOXG1 mutated cells

被引：0
|
作者：
Croci, S. [1 ]
Daga, S. [1 ]
Lorenzetti, F. C. [1 ]
Papa, F. T. [1 ]
Donati, F. [2 ]
Lo Rizzo, C. [1 ,3 ]
Lopergolo, D. [1 ,3 ]
Pancrazi, L. [4 ]
Doria, M. [5 ]
Auricchio, A. [5 ]
Costa, M. [4 ]
Conticello, S. [2 ]
Renieri, A. [1 ,3 ]
Meloni, I. [1 ]
机构：
[1] Univ Siena, Med Genet, Siena, Italy
[2] ITT Core Res Lab CRL, Mol Mech Oncogenesis, Florence, Italy
[3] Azienda Osped Univ Senese, Genet Med, Siena, Italy
[4] Italian Natl Res Council CNR, Lab Neurophysiol, Inst Neurosci, Pisa, Italy
[5] TIGEM Telethon Inst Genet & Med, Pozzuoli, Italy
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2019年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
C20.5
引用
收藏
页码：853 / 853
页数：1
相关论文
共 50 条
  • [21] Generation of isogenic and homozygous MEN1 mutant cell lines from patient-derived iPSCs using CRISPR/Cas9
    Even-Zohar, Naomi
    Metin-Armagan, Derya
    Ben-Shlomo, Anat
    Sareen, Dhruv
    Melmed, Shlomo
    Ornelas, Loren
    STEM CELL RESEARCH, 2023, 69
  • [22] CRISPR/Cas9 Screen in Gastric Cancer Patient-Derived Organoids Reveals KDM1A-NDRG1 Axis as a Targetable Vulnerability
    Mircetic, Jovan
    Camgoez, Aylin
    Abohawya, Moustafa
    Ding, Li
    Dietzel, Julia
    Tobar, Sebastian Garcia
    Paszkowski-Rogacz, Maciej
    Seidlitz, Therese
    Schmaeche, Tim
    Mehnert, Marie-Christin
    Sidorova, Olga
    Weitz, Juergen
    Buchholz, Frank
    Stange, Daniel E.
    SMALL METHODS, 2023, 7 (06)
  • [23] Application of CRISPR/Cas9 system in the generation of YB1 knockout cells for AAV vector production
    Miah, K.
    Satkunanathan, S.
    Neuman, B.
    Jones, I.
    Zhao, Y.
    HUMAN GENE THERAPY, 2016, 27 (11) : A170 - A170
  • [24] Myogenic Differentiation from MYOGENIN-Mutated Human iPS Cells by CRISPR/Cas9
    Higashioka, Koki
    Koizumi, Noriko
    Sakurai, Hidetoshi
    Sotozono, Chie
    Sato, Takahiko
    STEM CELLS INTERNATIONAL, 2017, 2017
  • [25] Different Methods of Delivering CRISPR/Cas9 Into Cells
    Chandrasekaran, Arun Pandian
    Song, Minjung
    Kim, Kye-Seong
    Ramakrishna, Suresh
    PROGRESS IN MOLECULAR BIOLOGY AND TRANSLATIONAL SCIENCE, VOL 159, 2018, 159 : 157 - 176
  • [26] CRISPR/Cas9-Mediated Gene Correction in Osteopetrosis Patient-Derived iPSCs
    Li, Dandan
    Ou, Minglin
    Zhang, Wei
    Luo, Qi
    Cai, Wanxia
    Mo, Chune
    Liang, Wenken
    Dai, Guandong
    Yin, Lianghong
    Zhu, Peng
    Tang, Donge
    Dai, Yong
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (06):
  • [27] CRISPR/Cas9 Genome Editing in LGMD2A/R1 Patient-Derived Induced Pluripotent Stem and Skeletal Muscle Progenitor Cells
    Mavrommatis, Lampros
    Zaben, Abdul
    Kindler, Urs
    Kienitz, Marie-Cecile
    Dietz, Julienne
    Jeong, Hyun-Woo
    Boehme, Pierre
    Brand-Saberi, Beate
    Vorgerd, Matthias
    Zaehres, Holm
    STEM CELLS INTERNATIONAL, 2023, 2023
  • [28] AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria
    Richards, Daelyn Y.
    Winn, Shelley R.
    Dudley, Sandra
    Nygaard, Sean
    Mighell, Taylor L.
    Grompe, Markus
    Harding, Cary O.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 17 : 234 - 245
  • [29] Genetic correction of concurrent α- and β-thalassemia patient-derived pluripotent stem cells by the CRISPR-Cas9 technology
    Li, Lingli
    Yi, Hongyan
    Liu, Zheng
    Long, Ping
    Pan, Tao
    Huang, Yuanhua
    Li, Yongsheng
    Li, Qi
    Ma, Yanlin
    STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [30] Genetic correction of concurrent α- and β-thalassemia patient-derived pluripotent stem cells by the CRISPR-Cas9 technology
    Lingli Li
    Hongyan Yi
    Zheng Liu
    Ping Long
    Tao Pan
    Yuanhua Huang
    Yongsheng Li
    Qi Li
    Yanlin Ma
    Stem Cell Research & Therapy, 13
12345